COMPLETE EXPERT EVALUATION ENSURES OUR SYSTEMS ARE COMPLIANT, EFFECTIVE AND ALIGNED WITH YOUR MANUFACTURING NEEDS

Good Manufacturing Practice (GMP)

I’NI Consulting Good Manufacturing Practice (GMP) experts can work to evaluate systems at your pharmaceutical, biotechnology, or medical device organization or at your vendor sites to determine if the systems in place are sufficient to meet your manufacturing needs and the current regulatory standards. As an extension of your GMP Auditing team, we’re able to conduct audits on your behalf, using your established audit program or the I’NI Consulting process, whichever works best for your needs.

Our GMP experts have experience auditing systems against applicable regulatory and industry standards. Our experts work with you to apply the correct standards based on your needs, the activities or services provided, and the stage of your project. During our evaluations, we can identify areas for improvement or potential compliance risks. We assess a wide range of systems—most notably those used in quality, production, packaging and labeling, materials, laboratories, distribution, and equipment and facilities.

Bespoke.
Dedicated.
Comprehensive.

OUR SUBJECT MATTER EXPERTS

Issa Yefeu
Sr. GMP Consultant
MSc Pharmaceutical Sciences

Issa is a Pharmacist by education with a MSc in Pharmaceutical Sciences from the University of Oporto in Portugal.

Services Brochure

BE PREPARED FOR EVERY ASPECT OF GMP INSPECTIONS. AT I’NI Consulting WE CAN TRAIN EMPLOYEES ON INSPECTION INTERVIEW TECHNIQUES, CONDUCT GAP ANALYSIS ON YOUR SYSTEMS, PROCESSES, OR FACILITIES, FACILITATE FULL MOCK INSPECTIONS AND MORE.

FEATURED RESOURCES

For a deeper dive into the ICH E6(R3) guidelines, check out our latest expert insights.

WEBINAR

I'NI CONSULTING's webinar, "GCP ICH E6 R3 Unveiled: Navigating the Evolving Roles of Sponsors and CROs," provides invaluable insights into the evolving landscape of Good Clinical Practice (GCP) guidelines.

CASE STUDY

Our latest case study highlights how I'NI CONSULTING supported a leading pharmaceutical company in proactively identifying high-risk sites during a global Phase III oncology trial—aligning with ICH E6 (R3) guidelines.

GUIDE

In this free guide, we break down the most critical updates to ICH E6(R3)—and provide practical, inspection-ready strategies to help you stay compliant, audit-ready, and ahead of regulatory expectations.

I’NI CONSULTING CAN SUPPORT YOUR PROCESSES. WE PARTNER WITH YOUR ORGANIZATION TO CONDUCT FACILITY WALKTHROUGHS TO ASSIST IMPROVEMENTS THROUGHOUT THE COMPANY.

ARTICLES AND INSIGHTS FROM I'NI Consulting

RQA Course: A System Approach to Good Pharmacovigilance Practice

INI Consulting is proud to support the professional development of pharmacovigilance (PV) specialists across the industry through active participation in the RQA’s highly…

DIA 2025 Global Annual Meeting | Washington, DC

INI Consulting looks forward to attending the upcoming DIA Global Annual Meeting 2025 that will take place in Washington, DC from 15–19 June.

2025 European QA Virtual Conference

INI Consulting Consulting is proud to be a Silver Sponsor of the 2025 RQA European QA Virtual Conference, the must-attend event for quality assurance…

LET'S START A CONVERSATION